Big Move For Marker Therapeutics, Inc.
Fri, Aug 05, 2022 at 07:14 PM
Marker Therapeutics, Inc. (MRKR:NASDAQ) soared at $0.54, a gain of 63.6%. On Fri, Aug 05, 2022, MRKR:NASDAQ touched a New 2-Week High of $0.54. The stock got featured on our News Catalysts scanner on Thu, Aug 04, 2022 at 05:23 PM in the 'BIOTECH' category. From Fri, Jul 22, 2022, the stock recorded 40.00% Up Days and 18.18% Green Days
About Marker Therapeutics, Inc. (MRKR:NASDAQ)
TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.
Top 10 Gainers:
- Cooper-Standard Holdings Inc. (CPS:NYSE), 69.58%
- Intelligent Living Application Group Inc. (ILAG:NASDAQ), 64.38%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 63.64%
- Athenex, Inc. (ATNX:NASDAQ), 51.61%
- Bonso Electronics International Inc. (BNSO:NASDAQ), 46.18%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 45.78%
- Heritage Insurance Holdings, Inc. (HRTG:NYSE), 44.03%
- AlerisLife Inc. (ALR:NASDAQ), 43.7%
- Carvana Co. (CVNA:NYSE), 40.07%
- Progyny, Inc. (PGNY:NASDAQ), 38.23%